SUNPHARMA — Sun Pharmaceutical Industries Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual balance sheet for Sun Pharmaceutical Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	R2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	113,666	95,633	127,169	151,477	200,224
Net Total Accounts Receivable
Net Total Receivables	99,257	93,248	121,851	129,598	113,144
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	316,542	304,421	348,646	398,619	434,331
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	112,263	111,715	111,689	113,537	113,001
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	682,525	676,667	698,078	807,436	854,629
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	157,064	161,456	172,085	199,064	169,838
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	229,880	212,040	217,966	247,482	217,961
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	452,645	464,628	480,112	559,954	636,668
Total Liabilities & Shareholders' Equity	682,525	676,667	698,078	807,436	854,629
Total Common Shares Outstanding